Hoffmann-La Roche: Anemia trials

The registry lists 106 Anemia studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 66 have results posted.

Phase 1 1Phase 2 8Phase 3 48Phase 4 23No phase 27(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.CompletedNCT00327535Phase 2
• A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144495Phase 3
• A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing ChemotherapyCompletedNCT00144482Phase 3
• A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00081484Phase 3
• A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on DialysisCompletedNCT00081471Phase 3
• A Study of Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNCT00077597Phase 3